On this page

Penmenvy

Meningococcal Groups A, B, C, W and Y Vaccine

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Penmenvy
Proper name
Meningococcal Groups A, B, C, W and Y Vaccine
Licence type
351(a)
BLA number
125819
Applicant
GlaxoSmithKline Biologicals
Center
CBER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
25UG/0.5ML Injection Intramuscular Single-Dose Vial Rx February 14, 2025

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity